1. |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin, 2016, 66(2): 115-132.
|
2. |
Hunter DJ, Kraft P, Jacobs KB, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet, 2007, 39(7): 870-874.
|
3. |
Brooks AN, Kilgour E, Smith PD. Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer. Clin Cancer Res, 2012, 18(7): 1855-1862.
|
4. |
Tannheimer SL, Rehemtulla A, Ethier SP. Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE. Breast Cancer Res, 2000, 2(4): 311-320.
|
5. |
Cui F, Wu D, Wang W, et al. Variants of FGFR2 and their associations with breast cancer risk: a HUGE systematic review and meta-analysis. Breast Cancer Res Treat, 2016, 155(2): 313-335.
|
6. |
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 2010, 25(9): 603-605.
|
7. |
Liang J, Chen P, Hu Z, et al. Genetic variants in fibroblast growth factor receptor 2(FGFR2) contribute to susceptibility of breast cancer in Chinese women. Carcinogenesis, 2008, 29(12): 2341-2346.
|
8. |
赵洪猛, 张斌, 姚慧, 等. FGFR2 基因多态性与乳腺癌易感性的相关性研究. 中国肿瘤临床, 2010, 37(11): 626-629.
|
9. |
张敬平, 钱云, 王福如, 等. 成纤维细胞生长因子受体 2(FGFR2)多态性与乳腺癌易感性的关联研究. 中华疾病控制杂志, 2010, 14(8): 764-767.
|
10. |
胡飞飞, 周菁, 庞柯, 等. 湖北地区人群乳腺癌易感基因 FGFR2 多态性研究. 中华肿瘤防治杂志, 2011, 18(2): 89-91.
|
11. |
Chen F, Lu M, Xue Y, et al. Genetic variants of fibroblast growth factor receptor 2 (FGFR2) are associated with breast cancer risk in Chinese women of the Han nationality. Immunogenetics, 2012, 64(1): 71-76.
|
12. |
Fu F, Wang C, Huang M, et al. Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han women. Tohoku J Exp Med, 2012, 226(3): 221-229.
|
13. |
Chan M, Ji SM, Liaw CS, et al. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population. Breast Cancer Res Treat, 2012, 136(1): 209-220.
|
14. |
Liu CL, Hu XP, Guo WD, et al. Case-control study on the fibroblast growth factor receptor 2 gene polymorphisms associated with breast cancer in Chinese han women. J Breast Cancer, 2013, 16(4): 366-371.
|
15. |
潘琳, 胡小平, 郭卫东, 等. FGFR2 基因 rs2981582 和 rs1219648 与乳腺癌相关性研究. 宁夏医科大学学报, 2014, 36(8): 853-856.
|
16. |
Xi J, Su Y, Beeghly Fadiel A, et al. Association of physical activity and polymorphisms in FGFR2 and DNA methylation related genes with breast cancer risk. Cancer Epidemiol, 2014, 38(6): 708-714.
|
17. |
沈国双, 郑方超, 曹成珠, 等. 青海地区藏族 FGFR2 基因多态性与乳腺癌的相关性研究. 重庆医学, 2016, 45(16): 2209-2211.
|
18. |
Siddiqui S, Chattopadhyay S, Akhtar MS, et al. A study on genetic variants of fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India. PLoS One, 2014, 9(10): e110426.
|
19. |
Katoh Y, Katoh M. FGFR2-related pathogenesis and FGFR2-targeted therapeutics (review). Int J Mol Med, 2009, 23(3): 307-311.
|
20. |
Yang YB, Zhao ZX, Huang W, et al. Association between fibroblast growth factor receptor-2 gene polymorphism and risk of breast cancer in Chinese populations: a HuGE review and meta-analysis. J Cancer Res Ther, 2016, 12(2): 543-549.
|
21. |
Easton DF, Pooley KA, Dunning AM, et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 2007, 447(7148): 1087-1093.
|
22. |
Garcia-Closas M, Hall P, Nevanlinna H, et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet, 2008, 4(4): e1000054.
|
23. |
查国松, 左文述. BRCA1 与乳腺癌的研究进展. 中国普外基础与临床杂志, 2017, 24(7): 900-904.
|
24. |
Antoniou AC, Spurdle AB, Sinilnikova OM, et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet, 2008, 82(4): 937-948.
|
25. |
陈洁, 吕青, 王竹, 等. 乳腺癌分子病理学指标分布的异质性. 中国普外基础与临床杂志, 2016, 23(6): 761-766.
|